Structural Heart Disease Intervention Devices - Global and China Top Players Market Share and Ranking 2023
According to the research report published by Market IntelliX, the global market for Structural Heart Disease Intervention Devices should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Structural Heart Disease Intervention Devices market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Structural Heart Disease Intervention Devices market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Congenital Heart Disease Treatment grew percent to account for percent of the total market sales, and Valvular Heart Disease Treatment grew percent.
Structural heart disease intervention devices are medical devices used to treat heart diseases by repairing or replacing diseased or defective heart tissues or structures through minimally invasive procedures. Common types of structural heart disease intervention devices include:
Atrial septal defect closure devices: used to treat congenital heart defects by inserting a device into the heart through a catheter and placing a closure device over the defect to prevent blood from flowing from the left atrium to the right atrium.
Mitral valve repair devices: used to treat mitral valve regurgitation or prolapse by inserting a device into the heart through a catheter and placing a repair device over the damaged or prolapsed valve.
Transcatheter aortic valve replacement devices: used to treat aortic valve stenosis or regurgitation by inserting an artificial valve into the heart through a catheter and replacing the damaged aortic valve.
Cerebral aneurysm coiling devices: used to treat cerebral aneurysms or narrowing of the blood vessels in the brain by inserting a coil into the blood vessel through a catheter to strengthen the blood vessel and prevent blood from leaking out.
These structural heart disease intervention devices have been widely used in clinical practice and have achieved good treatment results, significantly improving the cardiovascular function of patients and enhancing their quality of life.
This report studies and analyses global Structural Heart Disease Intervention Devices status and future trends, helps the client to determine the Structural Heart Disease Intervention Devices market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Structural Heart Disease Intervention Devices, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Structural Heart Disease Intervention Devices market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (K Units)
(2) Global Structural Heart Disease Intervention Devices sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(3) China Structural Heart Disease Intervention Devices sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(4) Global Structural Heart Disease Intervention Devices key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Structural Heart Disease Intervention Devices key producing regions, capacity, production, and year over year growth
(6) Structural Heart Disease Intervention Devices industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Abbott Structural Heart
Philips
Japen Lifeline
Neovasc
Append Medical
Transverse Medical
Cardiomech
Thubrikar Aortic Valve Inc
Boston Scientific
Edwards Lifesciences Corporation
Biomerics
LivaNova PLC
Market segment by Type, covers
Atrial Interventional Class
Cardiovascular Intervention
Market segment by Application, can be divided into
Congenital Heart Disease Treatment
Valvular Heart Disease Treatment
Cardiomyopathy Treatment
Aneurysm and Arterial Valve Disease Treatment
Others
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Structural Heart Disease Intervention Devices product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Structural Heart Disease Intervention Devices market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China Structural Heart Disease Intervention Devices market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of Structural Heart Disease Intervention Devices, percent & CAGR, 2018-2029
Chapter 5: Structural Heart Disease Intervention Devices industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Structural Heart Disease Intervention Devices Definition
1.2 Global Structural Heart Disease Intervention Devices Market Size and Forecast
1.2.1 By Consumption Value, Global Structural Heart Disease Intervention Devices Market Size，2018-2029
1.2.2 By Sales Quantity, Global Structural Heart Disease Intervention Devices Market Size，2018-2029
1.2.3 Global Structural Heart Disease Intervention Devices Average Selling Price (ASP)，2018-2029
1.3 China Structural Heart Disease Intervention Devices Market Size and Forecast
1.3.1 By Consumption Value, China Structural Heart Disease Intervention Devices Market Size，2018-2029
1.3.2 By Sales Quantity, China Structural Heart Disease Intervention Devices Market Size，2018-2029
1.3.3 China Structural Heart Disease Intervention Devices Average Selling Price (ASP)， 2018-2029
1.4 Share of China Structural Heart Disease Intervention Devices Market with Respect to the Global Market
1.4.1 By Consumption Value, China Structural Heart Disease Intervention Devices Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China Structural Heart Disease Intervention Devices Market Share in Global, 2018-2029
1.4.3 Structural Heart Disease Intervention Devices Market Size: China VS Global, 2018-2029
1.5 Structural Heart Disease Intervention Devices Market Dynamics
1.5.1 Structural Heart Disease Intervention Devices Market Drivers
1.5.2 Structural Heart Disease Intervention Devices Market Restraints
1.5.3 Structural Heart Disease Intervention Devices Industry Trends
1.5.4 Structural Heart Disease Intervention Devices Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Structural Heart Disease Intervention Devices, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of Structural Heart Disease Intervention Devices, Global Market Share by Company, 2018-2023
2.3 Structural Heart Disease Intervention Devices Average Selling Price (ASP) by Company, 2018-2023
2.4 Global Structural Heart Disease Intervention Devices Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Structural Heart Disease Intervention Devices Concentration Ratio
2.6 Global Structural Heart Disease Intervention Devices Mergers & Acquisitions, Expansion Plans
2.7 Global Structural Heart Disease Intervention Devices Manufacturers Product Type
2.8 Head Office and Structural Heart Disease Intervention Devices Production Site of Key Manufacturer
2.9 Structural Heart Disease Intervention Devices Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Structural Heart Disease Intervention Devices, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of Structural Heart Disease Intervention Devices, China Market Share by Company, 2018-2023
3.3 China Structural Heart Disease Intervention Devices Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Structural Heart Disease Intervention Devices Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global Structural Heart Disease Intervention Devices Capacity by Region
4.3 Global Structural Heart Disease Intervention Devices Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global Structural Heart Disease Intervention Devices Production by Region, 2018-2029
4.5 Global Structural Heart Disease Intervention Devices Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Structural Heart Disease Intervention Devices Industry Chain
5.2 Structural Heart Disease Intervention Devices Upstream Analysis
5.2.1 Structural Heart Disease Intervention Devices Core Raw Materials
5.2.2 Main Manufacturers of Structural Heart Disease Intervention Devices Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Structural Heart Disease Intervention Devices Production Mode
5.6 Structural Heart Disease Intervention Devices Procurement Model
5.7 Structural Heart Disease Intervention Devices Industry Sales Model and Sales Channels
5.7.1 Structural Heart Disease Intervention Devices Sales Model
5.7.2 Structural Heart Disease Intervention Devices Typical Distributors
6 Sights by Type
6.1 Structural Heart Disease Intervention Devices Classification
6.1.1 Atrial Interventional Class
6.1.2 Cardiovascular Intervention
6.2 By Type, Global Structural Heart Disease Intervention Devices Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Structural Heart Disease Intervention Devices Consumption Value, 2018-2029
6.4 By Type, Global Structural Heart Disease Intervention Devices Sales Quantity, 2018-2029
6.5 By Type, Global Structural Heart Disease Intervention Devices Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 Structural Heart Disease Intervention Devices Segment by Application
7.1.1 Congenital Heart Disease Treatment
7.1.2 Valvular Heart Disease Treatment
7.1.3 Cardiomyopathy Treatment
7.1.4 Aneurysm and Arterial Valve Disease Treatment
7.1.5 Others
7.2 By Application, Global Structural Heart Disease Intervention Devices Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Structural Heart Disease Intervention Devices Consumption Value, 2018-2029
7.4 By Application, Global Structural Heart Disease Intervention Devices Sales Quantity, 2018-2029
7.5 By Application, Global Structural Heart Disease Intervention Devices Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Structural Heart Disease Intervention Devices Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global Structural Heart Disease Intervention Devices Consumption Value, 2018-2029
8.3 By Region, Global Structural Heart Disease Intervention Devices Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America Structural Heart Disease Intervention Devices & Forecasts, 2018-2029
8.4.2 By Country, North America Structural Heart Disease Intervention Devices Market Size Market Share
8.5 Europe
8.5.1 Europe Structural Heart Disease Intervention Devices Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Structural Heart Disease Intervention Devices Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Structural Heart Disease Intervention Devices Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Structural Heart Disease Intervention Devices Market Size Market Share
8.7 South America
8.7.1 South America Structural Heart Disease Intervention Devices Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Structural Heart Disease Intervention Devices Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Structural Heart Disease Intervention Devices Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global Structural Heart Disease Intervention Devices Consumption Value, 2018-2029
9.3 By Country, Global Structural Heart Disease Intervention Devices Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. Structural Heart Disease Intervention Devices Market Size, 2018-2029
9.4.2 By Type, U.S. Structural Heart Disease Intervention Devices Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. Structural Heart Disease Intervention Devices Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Structural Heart Disease Intervention Devices Market Size, 2018-2029
9.5.2 By Type, Europe Structural Heart Disease Intervention Devices Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe Structural Heart Disease Intervention Devices Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China Structural Heart Disease Intervention Devices Market Size, 2018-2029
9.6.2 By Type, China Structural Heart Disease Intervention Devices Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China Structural Heart Disease Intervention Devices Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Structural Heart Disease Intervention Devices Market Size, 2018-2029
9.7.2 By Type, Japan Structural Heart Disease Intervention Devices Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan Structural Heart Disease Intervention Devices Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Structural Heart Disease Intervention Devices Market Size, 2018-2029
9.8.2 By Type, South Korea Structural Heart Disease Intervention Devices Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea Structural Heart Disease Intervention Devices Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Structural Heart Disease Intervention Devices Market Size, 2018-2029
9.9.2 By Type, Southeast Asia Structural Heart Disease Intervention Devices Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia Structural Heart Disease Intervention Devices Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India Structural Heart Disease Intervention Devices Market Size, 2018-2029
9.10.2 By Type, India Structural Heart Disease Intervention Devices Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India Structural Heart Disease Intervention Devices Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa Structural Heart Disease Intervention Devices Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa Structural Heart Disease Intervention Devices Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa Structural Heart Disease Intervention Devices Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Abbott Structural Heart
10.1.1 Abbott Structural Heart Company Information, Head Office, Market Area, and Industry Position
10.1.2 Abbott Structural Heart Structural Heart Disease Intervention Devices Models, Specifications, and Application
10.1.3 Abbott Structural Heart Structural Heart Disease Intervention Devices Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Abbott Structural Heart Company Profile and Main Business
10.1.5 Abbott Structural Heart Recent Developments
10.2 Philips
10.2.1 Philips Company Information, Head Office, Market Area, and Industry Position
10.2.2 Philips Structural Heart Disease Intervention Devices Models, Specifications, and Application
10.2.3 Philips Structural Heart Disease Intervention Devices Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Philips Company Profile and Main Business
10.2.5 Philips Recent Developments
10.3 Japen Lifeline
10.3.1 Japen Lifeline Company Information, Head Office, Market Area, and Industry Position
10.3.2 Japen Lifeline Structural Heart Disease Intervention Devices Models, Specifications, and Application
10.3.3 Japen Lifeline Structural Heart Disease Intervention Devices Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Japen Lifeline Company Profile and Main Business
10.3.5 Japen Lifeline Recent Developments
10.4 Neovasc
10.4.1 Neovasc Company Information, Head Office, Market Area, and Industry Position
10.4.2 Neovasc Structural Heart Disease Intervention Devices Models, Specifications, and Application
10.4.3 Neovasc Structural Heart Disease Intervention Devices Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Neovasc Company Profile and Main Business
10.4.5 Neovasc Recent Developments
10.5 Append Medical
10.5.1 Append Medical Company Information, Head Office, Market Area, and Industry Position
10.5.2 Append Medical Structural Heart Disease Intervention Devices Models, Specifications, and Application
10.5.3 Append Medical Structural Heart Disease Intervention Devices Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Append Medical Company Profile and Main Business
10.5.5 Append Medical Recent Developments
10.6 Transverse Medical
10.6.1 Transverse Medical Company Information, Head Office, Market Area, and Industry Position
10.6.2 Transverse Medical Structural Heart Disease Intervention Devices Models, Specifications, and Application
10.6.3 Transverse Medical Structural Heart Disease Intervention Devices Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Transverse Medical Company Profile and Main Business
10.6.5 Transverse Medical Recent Developments
10.7 Cardiomech
10.7.1 Cardiomech Company Information, Head Office, Market Area, and Industry Position
10.7.2 Cardiomech Structural Heart Disease Intervention Devices Models, Specifications, and Application
10.7.3 Cardiomech Structural Heart Disease Intervention Devices Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Cardiomech Company Profile and Main Business
10.7.5 Cardiomech Recent Developments
10.8 Thubrikar Aortic Valve Inc
10.8.1 Thubrikar Aortic Valve Inc Company Information, Head Office, Market Area, and Industry Position
10.8.2 Thubrikar Aortic Valve Inc Structural Heart Disease Intervention Devices Models, Specifications, and Application
10.8.3 Thubrikar Aortic Valve Inc Structural Heart Disease Intervention Devices Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Thubrikar Aortic Valve Inc Company Profile and Main Business
10.8.5 Thubrikar Aortic Valve Inc Recent Developments
10.9 Boston Scientific
10.9.1 Boston Scientific Company Information, Head Office, Market Area, and Industry Position
10.9.2 Boston Scientific Structural Heart Disease Intervention Devices Models, Specifications, and Application
10.9.3 Boston Scientific Structural Heart Disease Intervention Devices Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Boston Scientific Company Profile and Main Business
10.9.5 Boston Scientific Recent Developments
10.10 Edwards Lifesciences Corporation
10.10.1 Edwards Lifesciences Corporation Company Information, Head Office, Market Area, and Industry Position
10.10.2 Edwards Lifesciences Corporation Structural Heart Disease Intervention Devices Models, Specifications, and Application
10.10.3 Edwards Lifesciences Corporation Structural Heart Disease Intervention Devices Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Edwards Lifesciences Corporation Company Profile and Main Business
10.10.5 Edwards Lifesciences Corporation Recent Developments
10.11 Biomerics
10.11.1 Biomerics Company Information, Head Office, Market Area, and Industry Position
10.11.2 Biomerics Structural Heart Disease Intervention Devices Models, Specifications, and Application
10.11.3 Biomerics Structural Heart Disease Intervention Devices Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Biomerics Company Profile and Main Business
10.11.5 Biomerics Recent Developments
10.12 LivaNova PLC
10.12.1 LivaNova PLC Company Information, Head Office, Market Area, and Industry Position
10.12.2 LivaNova PLC Structural Heart Disease Intervention Devices Models, Specifications, and Application
10.12.3 LivaNova PLC Structural Heart Disease Intervention Devices Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.12.4 LivaNova PLC Company Profile and Main Business
10.12.5 LivaNova PLC Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Structural Heart Disease Intervention Devices Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Structural Heart Disease Intervention Devices Market Restraints
Table 3. Structural Heart Disease Intervention Devices Market Trends
Table 4. Structural Heart Disease Intervention Devices Industry Policy
Table 5. Global Structural Heart Disease Intervention Devices Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Structural Heart Disease Intervention Devices Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Structural Heart Disease Intervention Devices Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 8. Global Structural Heart Disease Intervention Devices Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Structural Heart Disease Intervention Devices Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)
Table 10. Global Structural Heart Disease Intervention Devices Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Structural Heart Disease Intervention Devices Mergers & Acquisitions, Expansion Plans
Table 12. Global Structural Heart Disease Intervention Devices Manufacturers Product Type
Table 13. Head Office and Structural Heart Disease Intervention Devices Production Site of Key Manufacturer
Table 14. Structural Heart Disease Intervention Devices Capacity of Major Manufacturers and Future Plan
Table 15. China Structural Heart Disease Intervention Devices Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Structural Heart Disease Intervention Devices Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 17. China Structural Heart Disease Intervention Devices Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Structural Heart Disease Intervention Devices Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 19. Global Structural Heart Disease Intervention Devices Production by Region, 2018-2023, (K Units)
Table 20. Global Structural Heart Disease Intervention Devices Production Forecast by Region, 2024-2029, (K Units)
Table 21. Global Key Players of Structural Heart Disease Intervention Devices Upstream (Raw Materials)
Table 22. Global Structural Heart Disease Intervention Devices Typical Customers
Table 23. Structural Heart Disease Intervention Devices Typical Distributors
Table 24. By Type, Global Structural Heart Disease Intervention Devices Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global Structural Heart Disease Intervention Devices Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Structural Heart Disease Intervention Devices Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Structural Heart Disease Intervention Devices Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Structural Heart Disease Intervention Devices Sales Quantity, 2018-2029, (K Units)
Table 29. By Country, Global Structural Heart Disease Intervention Devices Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Structural Heart Disease Intervention Devices Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Structural Heart Disease Intervention Devices Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Structural Heart Disease Intervention Devices Sales Quantity, 2018-2029, (K Units)
Table 33. By Country, Global Structural Heart Disease Intervention Devices Sales Quantity Market Share, 2018-2029
Table 34. Abbott Structural Heart Company Information, Head Office, Market Area, and Industry Position
Table 35. Abbott Structural Heart Structural Heart Disease Intervention Devices Models, Specifications, and Application
Table 36. Abbott Structural Heart Structural Heart Disease Intervention Devices Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 37. Abbott Structural Heart Company Profile and Main Business
Table 38. Abbott Structural Heart Recent Developments
Table 39. Philips Company Information, Head Office, Market Area, and Industry Position
Table 40. Philips Structural Heart Disease Intervention Devices Models, Specifications, and Application
Table 41. Philips Structural Heart Disease Intervention Devices Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Philips Company Profile and Main Business
Table 43. Philips Recent Developments
Table 44. Japen Lifeline Company Information, Head Office, Market Area, and Industry Position
Table 45. Japen Lifeline Structural Heart Disease Intervention Devices Models, Specifications, and Application
Table 46. Japen Lifeline Structural Heart Disease Intervention Devices Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Japen Lifeline Company Profile and Main Business
Table 48. Japen Lifeline Recent Developments
Table 49. Neovasc Company Information, Head Office, Market Area, and Industry Position
Table 50. Neovasc Structural Heart Disease Intervention Devices Models, Specifications, and Application
Table 51. Neovasc Structural Heart Disease Intervention Devices Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Neovasc Company Profile and Main Business
Table 53. Neovasc Recent Developments
Table 54. Append Medical Company Information, Head Office, Market Area, and Industry Position
Table 55. Append Medical Structural Heart Disease Intervention Devices Models, Specifications, and Application
Table 56. Append Medical Structural Heart Disease Intervention Devices Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Append Medical Company Profile and Main Business
Table 58. Append Medical Recent Developments
Table 59. Transverse Medical Company Information, Head Office, Market Area, and Industry Position
Table 60. Transverse Medical Structural Heart Disease Intervention Devices Models, Specifications, and Application
Table 61. Transverse Medical Structural Heart Disease Intervention Devices Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Transverse Medical Company Profile and Main Business
Table 63. Transverse Medical Recent Developments
Table 64. Cardiomech Company Information, Head Office, Market Area, and Industry Position
Table 65. Cardiomech Structural Heart Disease Intervention Devices Models, Specifications, and Application
Table 66. Cardiomech Structural Heart Disease Intervention Devices Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Cardiomech Company Profile and Main Business
Table 68. Cardiomech Recent Developments
Table 69. Thubrikar Aortic Valve Inc Company Information, Head Office, Market Area, and Industry Position
Table 70. Thubrikar Aortic Valve Inc Structural Heart Disease Intervention Devices Models, Specifications, and Application
Table 71. Thubrikar Aortic Valve Inc Structural Heart Disease Intervention Devices Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Thubrikar Aortic Valve Inc Company Profile and Main Business
Table 73. Thubrikar Aortic Valve Inc Recent Developments
Table 74. Boston Scientific Company Information, Head Office, Market Area, and Industry Position
Table 75. Boston Scientific Structural Heart Disease Intervention Devices Models, Specifications, and Application
Table 76. Boston Scientific Structural Heart Disease Intervention Devices Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Boston Scientific Company Profile and Main Business
Table 78. Boston Scientific Recent Developments
Table 79. Edwards Lifesciences Corporation Company Information, Head Office, Market Area, and Industry Position
Table 80. Edwards Lifesciences Corporation Structural Heart Disease Intervention Devices Models, Specifications, and Application
Table 81. Edwards Lifesciences Corporation Structural Heart Disease Intervention Devices Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Edwards Lifesciences Corporation Company Profile and Main Business
Table 83. Edwards Lifesciences Corporation Recent Developments
Table 84. Biomerics Company Information, Head Office, Market Area, and Industry Position
Table 85. Biomerics Structural Heart Disease Intervention Devices Models, Specifications, and Application
Table 86. Biomerics Structural Heart Disease Intervention Devices Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Biomerics Company Profile and Main Business
Table 88. Biomerics Recent Developments
Table 89. LivaNova PLC Company Information, Head Office, Market Area, and Industry Position
Table 90. LivaNova PLC Structural Heart Disease Intervention Devices Models, Specifications, and Application
Table 91. LivaNova PLC Structural Heart Disease Intervention Devices Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. LivaNova PLC Company Profile and Main Business
Table 93. LivaNova PLC Recent Developments
List of Figures
Figure 1. Structural Heart Disease Intervention Devices Picture
Figure 2. Global Structural Heart Disease Intervention Devices Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global Structural Heart Disease Intervention Devices Sales Quantity, (K Units) & (2018-2029)
Figure 4. Global Structural Heart Disease Intervention Devices Average Selling Price (ASP), (2018-2029) & (US$/Unit)
Figure 5. China Structural Heart Disease Intervention Devices Consumption Value, (US$ million) & (2018-2029)
Figure 6. China Structural Heart Disease Intervention Devices Sales Quantity (K Units) & (2018-2029)
Figure 7. China Structural Heart Disease Intervention Devices Average Selling Price (ASP), (US$/Unit) & (2018-2029)
Figure 8. By Consumption Value, China Structural Heart Disease Intervention Devices Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China Structural Heart Disease Intervention Devices Market Share of Global, 2018-2029
Figure 10. Global Structural Heart Disease Intervention Devices Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Structural Heart Disease Intervention Devices Key Participants, Market Share, 2022
Figure 12. Global Structural Heart Disease Intervention Devices Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global Structural Heart Disease Intervention Devices Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Structural Heart Disease Intervention Devices Production Market Share & Forecast by Region, 2018-2029
Figure 15. Structural Heart Disease Intervention Devices Industry Chain
Figure 16. Structural Heart Disease Intervention Devices Procurement Model
Figure 17. Structural Heart Disease Intervention Devices Sales Model
Figure 18. Structural Heart Disease Intervention Devices Sales Channels, Direct Sales, and Distribution
Figure 19. Atrial Interventional Class
Figure 20. Cardiovascular Intervention
Figure 21. By Type, Global Structural Heart Disease Intervention Devices Consumption Value, 2018-2029, US$ Million
Figure 22. By Type, Global Structural Heart Disease Intervention Devices Consumption Value Market Share, 2018-2029
Figure 23. By Type, Global Structural Heart Disease Intervention Devices Sales Quantity, 2018-2029, (K Units)
Figure 24. By Type, Global Structural Heart Disease Intervention Devices Sales Quantity Market Share, 2018-2029
Figure 25. By Type, Global Structural Heart Disease Intervention Devices Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 26. Congenital Heart Disease Treatment
Figure 27. Valvular Heart Disease Treatment
Figure 28. Cardiomyopathy Treatment
Figure 29. Aneurysm and Arterial Valve Disease Treatment
Figure 30. Others
Figure 31. By Application, Global Structural Heart Disease Intervention Devices Consumption Value, 2018-2029, US$ Million
Figure 32. By Application, Global Structural Heart Disease Intervention Devices Consumption Value Market Share, 2018-2029
Figure 33. By Application, Global Structural Heart Disease Intervention Devices Sales Quantity, 2018-2029, (K Units)
Figure 34. By Application, Global Structural Heart Disease Intervention Devices Sales Quantity Market Share, 2018-2029
Figure 35. By Application, Global Structural Heart Disease Intervention Devices Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 36. By Region, Global Structural Heart Disease Intervention Devices Consumption Value Market Share, 2018-2029
Figure 37. By Region, Global Structural Heart Disease Intervention Devices Sales Quantity Market Share, 2018-2029
Figure 38. North America Structural Heart Disease Intervention Devices Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 39. By Country, North America Structural Heart Disease Intervention Devices Consumption Value Market Share, 2022
Figure 40. Europe Structural Heart Disease Intervention Devices Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 41. By Country, Europe Structural Heart Disease Intervention Devices Consumption Value Market Share, 2022
Figure 42. Asia Pacific Structural Heart Disease Intervention Devices Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 43. By Country/Region, Asia Pacific Structural Heart Disease Intervention Devices Consumption Value Market Share, 2022
Figure 44. South America Structural Heart Disease Intervention Devices Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 45. By Country, South America Structural Heart Disease Intervention Devices Consumption Value Market Share, 2022
Figure 46. Middle East & Africa Structural Heart Disease Intervention Devices Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 47. U.S. Structural Heart Disease Intervention Devices Sales Quantity, 2018-2029, (K Units)
Figure 48. By Type, U.S. Structural Heart Disease Intervention Devices Sales Quantity Market Share, 2022 VS 2029
Figure 49. By Application, U.S. Structural Heart Disease Intervention Devices Sales Quantity Market Share, 2022 VS 2029
Figure 50. Europe Structural Heart Disease Intervention Devices Sales Quantity, 2018-2029, (K Units)
Figure 51. By Type, Europe Structural Heart Disease Intervention Devices Sales Quantity Market Share, 2022 VS 2029
Figure 52. By Application, Europe Structural Heart Disease Intervention Devices Sales Quantity Market Share, 2022 VS 2029
Figure 53. China Structural Heart Disease Intervention Devices Sales Quantity, 2018-2029, (K Units)
Figure 54. By Type, China Structural Heart Disease Intervention Devices Sales Quantity Market Share, 2022 VS 2029
Figure 55. By Application, China Structural Heart Disease Intervention Devices Sales Quantity Market Share, 2022 VS 2029
Figure 56. Japan Structural Heart Disease Intervention Devices Sales Quantity, 2018-2029, (K Units)
Figure 57. By Type, Japan Structural Heart Disease Intervention Devices Sales Quantity Market Share, 2022 VS 2029
Figure 58. By Application, Japan Structural Heart Disease Intervention Devices Sales Quantity Market Share, 2022 VS 2029
Figure 59. South Korea Structural Heart Disease Intervention Devices Sales Quantity, 2018-2029, (K Units)
Figure 60. By Type, South Korea Structural Heart Disease Intervention Devices Sales Quantity Market Share, 2022 VS 2029
Figure 61. By Application, South Korea Structural Heart Disease Intervention Devices Sales Quantity Market Share, 2022 VS 2029
Figure 62. Southeast Asia Structural Heart Disease Intervention Devices Sales Quantity, 2018-2029, (K Units)
Figure 63. By Type, Southeast Asia Structural Heart Disease Intervention Devices Sales Quantity Market Share, 2022 VS 2029
Figure 64. By Application, Southeast Asia Structural Heart Disease Intervention Devices Sales Quantity Market Share, 2022 VS 2029
Figure 65. India Structural Heart Disease Intervention Devices Sales Quantity, 2018-2029, (K Units)
Figure 66. By Type, India Structural Heart Disease Intervention Devices Sales Quantity Market Share, 2022 VS 2029
Figure 67. By Application, India Structural Heart Disease Intervention Devices Sales Quantity Market Share, 2022 VS 2029
Figure 68. Middle East & Africa Structural Heart Disease Intervention Devices Sales Quantity, 2018-2029, (K Units)
Figure 69. By Type, Middle East & Africa Structural Heart Disease Intervention Devices Sales Quantity Market Share, 2022 VS 2029
Figure 70. By Application, Middle East & Africa Structural Heart Disease Intervention Devices Sales Quantity Market Share, 2022 VS 2029
Figure 71. Research Methodology
Figure 72. Breakdown of Primary Interviews
Figure 73. Bottom-up and Top-down Approaches
Figure 74. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|